These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The neural-glial purinergic receptor ensemble in chronic pain states. Jarvis MF Trends Neurosci; 2010 Jan; 33(1):48-57. PubMed ID: 19914722 [TBL] [Abstract][Full Text] [Related]
3. The regulation of osteoblast function and bone mineralisation by extracellular nucleotides: The role of p2x receptors. Orriss IR; Key ML; Brandao-Burch A; Patel JJ; Burnstock G; Arnett TR Bone; 2012 Sep; 51(3):389-400. PubMed ID: 22749889 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory role of supraspinal P2X3/P2X2/3 subtypes on nociception in rats. Fukui M; Nakagawa T; Minami M; Satoh M; Kaneko S Mol Pain; 2006 Jun; 2():19. PubMed ID: 16753051 [TBL] [Abstract][Full Text] [Related]
6. Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states. Donnelly-Roberts DL; Jarvis MF Br J Pharmacol; 2007 Jul; 151(5):571-9. PubMed ID: 17471177 [TBL] [Abstract][Full Text] [Related]
7. Characterization of three diaminopyrimidines as potent and selective antagonists of P2X3 and P2X2/3 receptors with in vivo efficacy in a pain model. Ballini E; Virginio C; Medhurst SJ; Summerfield SG; Aldegheri L; Buson A; Carignani C; Chen YH; Giacometti A; Lago I; Powell AJ; Jarolimek W Br J Pharmacol; 2011 Jul; 163(6):1315-25. PubMed ID: 21410458 [TBL] [Abstract][Full Text] [Related]
8. The Molecular Determinants of Small-Molecule Ligand Binding at P2X Receptors. Pasqualetto G; Brancale A; Young MT Front Pharmacol; 2018; 9():58. PubMed ID: 29456508 [TBL] [Abstract][Full Text] [Related]
9. Purinergic P2 receptors as targets for novel analgesics. Burnstock G Pharmacol Ther; 2006 Jun; 110(3):433-54. PubMed ID: 16226312 [TBL] [Abstract][Full Text] [Related]
10. Nociceptive signaling mediated by P2X3, P2X4 and P2X7 receptors. Inoue K; Tsuda M Biochem Pharmacol; 2021 May; 187():114309. PubMed ID: 33130129 [TBL] [Abstract][Full Text] [Related]
11. Molecular physiology of P2X receptors. North RA Physiol Rev; 2002 Oct; 82(4):1013-67. PubMed ID: 12270951 [TBL] [Abstract][Full Text] [Related]
12. Identification of aurintricarboxylic acid as a potent allosteric antagonist of P2X1 and P2X3 receptors. Obrecht AS; Urban N; Schaefer M; Röse A; Kless A; Meents JE; Lampert A; Abdelrahman A; Müller CE; Schmalzing G; Hausmann R Neuropharmacology; 2019 Nov; 158():107749. PubMed ID: 31461640 [TBL] [Abstract][Full Text] [Related]
13. P2X receptors: New players in cancer pain. Franceschini A; Adinolfi E World J Biol Chem; 2014 Nov; 5(4):429-36. PubMed ID: 25426266 [TBL] [Abstract][Full Text] [Related]
14. Contributions of P2X3 homomeric and heteromeric channels to acute and chronic pain. Jarvis MF Expert Opin Ther Targets; 2003 Aug; 7(4):513-22. PubMed ID: 12885270 [TBL] [Abstract][Full Text] [Related]
15. P2X purinergic receptor knockout mice reveal endogenous ATP modulation of both vasopressin and oxytocin release from the intact neurohypophysis. Custer EE; Knott TK; Cuadra AE; Ortiz-Miranda S; Lemos JR J Neuroendocrinol; 2012 Apr; 24(4):674-80. PubMed ID: 22340257 [TBL] [Abstract][Full Text] [Related]
16. AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist. Gever JR; Soto R; Henningsen RA; Martin RS; Hackos DH; Panicker S; Rubas W; Oglesby IB; Dillon MP; Milla ME; Burnstock G; Ford AP Br J Pharmacol; 2010 Jul; 160(6):1387-98. PubMed ID: 20590629 [TBL] [Abstract][Full Text] [Related]
17. Nociceptive transmission and modulation via P2X receptors in central pain syndrome. Kuan YH; Shyu BC Mol Brain; 2016 May; 9(1):58. PubMed ID: 27230068 [TBL] [Abstract][Full Text] [Related]
18. Evidence for the involvement of spinal endogenous ATP and P2X receptors in nociceptive responses caused by formalin and capsaicin in mice. Tsuda M; Ueno S; Inoue K Br J Pharmacol; 1999 Dec; 128(7):1497-504. PubMed ID: 10602329 [TBL] [Abstract][Full Text] [Related]
19. Pharmacology of cloned P2X receptors. North RA; Surprenant A Annu Rev Pharmacol Toxicol; 2000; 40():563-80. PubMed ID: 10836147 [TBL] [Abstract][Full Text] [Related]